- Home
- CLRB vs BRN Comparison
CLRB vs BRN Comparison
Compare CLRB & BRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLRB | BRN |
|---|---|---|
| Founded | 2002 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 13.2M |
| IPO Year | 2008 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CLRB | BRN |
|---|---|---|
| Price | $2.75 | $1.08 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.9K | ★ 304.0K |
| Earning Date | 06-10-2026 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $13,697,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.23 | $0.92 |
| 52 Week High | $10.19 | $2.28 |
Technical Indicators
Market Signals| Indicator | CLRB | BRN |
|---|---|---|
| Relative Strength Index (RSI) | 41.00 | 48.54 |
| Support Level | $2.55 | N/A |
| Resistance Level | $3.60 | $1.31 |
| Average True Range (ATR) | 0.25 | 0.15 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 17.24 | 35.01 |
Price Performance
Historical ComparisonAbout CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas company engaged in the acquisition, development, production, and sale of crude oil and natural gas. The Company operates through two segments: the Oil and Natural Gas segment, which focuses on oil and natural gas development, production, acquisitions, and sales in the United States and Canada; and the Land Investment segment, which owns leasehold land interests in Hawaii. The Company generates the majority of its revenue from the Oil and Natural Gas segment. The company operates in two geographic regions, the United States and Canada, with Canada contributing the majority of revenue.